← All comparisons
Head-to-head · FAERS comparison

Naproxen vs Meloxicam: side effects in FDA adverse event reports

Naproxen profile · Meloxicam profile · data 2026-09-14
How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

NaproxenMeloxicam
Drug classNonsteroidal Anti-inflammatory DrugNonsteroidal Anti-inflammatory Drug
Brand names––
FAERS reports142,02957,729
Serious61%58%
Death outcome11,4723,732
Boxed warningYes RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS Cardiovascular Thrombotic Events • Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased rYes RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS See full prescribing information

Signals both drugs share

ReactionNaproxenMeloxicamLabel screen (A / B)
Duodenal ulcer perforation2,535 · PRR 77.9648 · PRR 35.1Labeled — boxed warning / Labeled — boxed warning
Muscle injury2,008 · PRR 47.7509 · PRR 24.0Labeled (related wording) / Not in label — unassessed
Peripheral venous disease1,263 · PRR 68.2305 · PRR 30.0Not in label — unassessed / Labeled (related wording)
Porphyria acute294 · PRR 39.8163 · PRR 48.5Labeled (related wording) / Not in label — unassessed
Hand deformity2,837 · PRR 40.7787 · PRR 23.2Not in label — unassessed / Not in label — unassessed
Helicobacter infection2,516 · PRR 48.2615 · PRR 23.3Not in label — unassessed / Not in label — unassessed
Rheumatic fever2,066 · PRR 133.1557 · PRR 53.0Likely indication confounding / Likely indication confounding
Facet joint syndrome1,649 · PRR 163.1315 · PRR 40.2Not in label — unassessed / Not in label — unassessed
Deep vein thrombosis postoperative984 · PRR 149.5491 · PRR 121.4Not in label — unassessed / Not in label — unassessed
Dislocation of vertebra953 · PRR 110.9260 · PRR 48.0Not in label — unassessed / Not in label — unassessed
Adjustment disorder with depressed mood871 · PRR 112.6283 · PRR 59.2Not in label — unassessed / Not in label — unassessed
Lupus vulgaris613 · PRR 157.8274 · PRR 108.7Not in label — unassessed / Not in label — unassessed
Retinitis426 · PRR 50.4185 · PRR 45.2Not in label — unassessed / Not in label — unassessed
Seronegative arthritis318 · PRR 58.279 · PRR 27.4Likely indication confounding / Likely indication confounding
Grip strength128 · PRR 183.4127 · PRR 444.9Not in label — unassessed / Not in label — unassessed
Swollen joint count124 · PRR 150.882 · PRR 182.0Not in label — unassessed / Not in label — unassessed

Labeled signals distinctive to Naproxen

  • None stood out among the strongest labeled signals.

Labeled signals distinctive to Meloxicam

Common questions

Which has more reported side effects, Naproxen or Meloxicam?

Naproxen has 142,029 FAERS reports and Meloxicam 57,729. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (61% vs 58%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Naproxen and Meloxicam share?

Both drugs carry disproportionality signals for duodenal ulcer perforation, muscle injury, peripheral venous disease, porphyria acute, hand deformity. Shared signals often reflect a shared drug class or the condition both are used for.

Is Naproxen or Meloxicam safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.